Evaluation of a Blood Biomarker to Try and Distinguish Between the Presence or Absence of Aggressive Prostate Cancer

Follow-Up Study for Men Diagnosed With Prostate Cancer Through Participation in a Prostate Specific Antigen Screening Program

NCT00035217 ·Status: COMPLETED

Study of Blood and Tissue Samples From Patients Receiving Androgen Deprivation for Newly Diagnosed Prostate Cancer

NCT00967954 ·Status: UNKNOWN ·Phase: NA

Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer

NCT04812366 ·Status: RECRUITING ·Phase: PHASE2

Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT Trial

NCT04513717 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

PRostate Cancer Individual Signature Evaluation Trial in Patients Undergoing Scheduled Prostate Biopsy

NCT00966095 ·Status: UNKNOWN

Biomarkers of Bone Resorption in Metastatic Prostate Cancer

NCT01233557 ·Status: COMPLETED

Using Serum Parathyroid Hormones and Calcium to Improve Prostate Cancer Diagnosis

NCT02397629 ·Status: COMPLETED

Biomarkers in Bone Marrow and Blood Samples From Patients With Prostate Cancer Treated With Ketoconazole

NCT01275651 ·Status: WITHDRAWN

Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy

NCT00002924 ·Status: COMPLETED

Testing the Effects of Low Dose Apalutamide on Prostate-Specific Antigen (PSA) Levels in Men Scheduled for Removal of the Prostate Gland

NCT04530552 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

An Open-label Extension Study of PSMA ADC 2301 in mCRPC

NCT02020135 ·Status: COMPLETED ·Phase: PHASE2

Prostate-specific Membrane Antigen Antibody-Drug Conjugate in Subjects With Prostate Cancer

NCT01414283 ·Status: COMPLETED ·Phase: PHASE1

A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer

NCT05800665 ·Status: RECRUITING ·Phase: PHASE1

Extended Study of Prostate-specific Membrane Antigen Antibody-Drug Conjugate in Subjects With Prostate Cancer

NCT01414296 ·Status: COMPLETED ·Phase: PHASE1

Surgery in Treating Patients With Prostate Cancer

NCT00002938 ·Status: COMPLETED ·Phase: PHASE2

Study of Blood and Tumor Samples From Men With an Inherited Risk of Prostate Cancer

NCT00959023 ·Status: UNKNOWN

Valid Biomarkers in Blood to Predict the Response to Therapy in Prostate Cancer Patients

NCT03408964 ·Status: RECRUITING

Evaluation of Xaluritamig in High-Risk, Biochemically Recurrent, Non-metastatic Castrate-sensitive Prostate Cancer

NCT06555796 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

Assessment of Primary Androgen Deprivation Therapy for Non-metastatic Prostate Cancer Among Elderly

NCT00161252 ·Status: WITHDRAWN

Glycosylation of Exosomes in Prostate and Urothelial Carcinoma

NCT04960956 ·Status: TERMINATED

Active Surveillance SNEP Assay Registry Trial for Prostate Cancer

NCT04052048 ·Status: RECRUITING

Phase 2 Study of G-202 in Patients With Chemotherapy-Naïve Metastatic Castrate-Resistant Prostate Cancer

NCT01734681 ·Status: WITHDRAWN ·Phase: PHASE2

Pembrolizumab With Androgen Deprivation Therapy and Radiotherapy for the Treatment of Patients With High Risk Localized Prostate Cancer

NCT06528210 ·Status: WITHDRAWN ·Phase: PHASE2

SLPI for Prostate Cancer

NCT04854343 ·Status: UNKNOWN

Saracatinib in Treating Patients With Prostate Cancer

NCT01267266 ·Status: TERMINATED ·Phase: PHASE2